References
- Kaunitz A -M. Injectable contraception: the USA perspective. IPPF Med Bull 1992; 26(6)1–3
- Sorensen M B, Collins P, Ong P J, Webb C M, et al. Long term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation 2002; 106(13)1646–1651
- Piya-Anant M, Koetsawang S, Patrasupapong N, Dinchuen P, et al. Effectiveness of Cliofem® in the treatment of depot medroxyprogesterone acetate induced amenorrhoea. Contraception 1998; 57(1s)23–28
- Scholes D, LaCroix A Z, Ichikawa L E, Barlow W E, Ott S M. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 2005; 59(2)139–144
- Ott S M, Scholes D, LaCroix A Z, Ichikawa L E, et al. Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab 2001; 86(1)179–185
- Cundy T, Cornish J, Evans M C, Roberts H, Reid I R. Recovery of bone density in women who stop using medroxyprogesterone acetate. Br Med J 1994; 308(6923)247–248
- Croxatto. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception 2002; 65(1)21–27, Review
- Kaunitz A M. Beyond the pill: new data and options in hormonal intrauterine contraception. Am J Obstet Gynecol 2005; 192(4)998–1004, Review